Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2541-2558
Author(s):
T. W. Rockway, V. Nienaber and V. L. Giranda
Acyl-Gelatins for Cell-Hybrid Biomaterials: Preparation of Gelatins with High Melting Point and Affinity for Hydrophobic Surfaces
Journal:
Protein & Peptide Letters
Volume:
9
Page:
521-528
Author(s):
Keiichi Miyamoto, Hiroko Chinzei and Takashi Komai
Structure-based Design of Mimetics for Granulocyte-macrophage Colony Stimulating Factor (GM-CSF)
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2185-2199
Author(s):
Cristina Monfardini, Gabriela Canziani, Carmela Plugariu, Thomas Kieber -Emmons, A. Paul Godillot, Joann Kwah, Joanna Bajgier, Irwin Chaiken and William V. Williams
Kringle Structures and Antiangiogenesis
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
667-681
Author(s):
Yihai Cao, Renhai Cao and Niina Veitonmaki
Anti-infective Agents Produced by the Hyphomycetes Genera Trichoderma and Gliocladium
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
1
Page:
343-374
Author(s):
E. L. Ghisalberti
Proteoglycans in Inflammation
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
89-102
Author(s):
M. Delehedde, F. Allain, S. J. Payne, R. Borgo, C. Vanpouille, D. G. Fernig and E. Deudon
Macrolides as Immunomodulatory Agents
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
131-141
Author(s):
Patrick C. Y. Woo, Susanna K. P. Lau and Kwok-yung Yuen
Blood-Brain Barrier Penetration and Drug Development from an Industrial Point of View
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
187-201
Author(s):
Katharina Mertsch and Jochen Maas
Small Peptide Radiopharmaceuticals in the Imaging of Acute Thrombus
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1815-1826
Author(s):
Jay E. Blum and Hirsch Handmaker
Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1765-1780
Author(s):
Eric J. Friedman